BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2890230)

  • 1. T-cell lymphomas of the stomach: morphological and immunological studies characterizing two cases of T-cell lymphoma.
    Moubayed P; Kaiserling E; Stein H
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(6):523-9. PubMed ID: 2890230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-positive and -negative T-cell lymphomas. Morphological and immunohistochemical differences between European and HTLV-positive Japanese T-cell lymphomas.
    Lennert K; Kikuchi M; Sato E; Suchi T; Stansfeld AG; Feller AC; Hansmann ML; Müller-Hermelink HK; Gödde-Salz E
    Int J Cancer; 1985 Jan; 35(1):65-72. PubMed ID: 2578441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary intracranial malignant lymphomas a fine structural cytochemical and CSF immunological study.
    Jellinger K; Slowik F; Sluga E
    Clin Neurol Neurosurg; 1979; 81(3):173-84. PubMed ID: 230932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histochemistry of dipeptidyl aminopeptidase (DAP) II and IV in reactive lymphoid tissues and malignant lymphoma.
    Khalaf MR; Aqel NM; Hayhoe FG
    J Clin Pathol; 1987 May; 40(5):480-5. PubMed ID: 2884235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistocytochemical correlation of DAP IV-CD 26 reactivity with immunologic markers of lymphocyte activation in human lymphoid tissues.
    Cozzi M; Gloghini A; Volpe R; Carbone A
    Br J Haematol; 1990 Jul; 75(3):325-32. PubMed ID: 1974815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In situ - demonstration of helper-T-lymphocytes in cutaneous malignant lymphomas by diaminopeptidase IV (DAP IV)].
    Sterry W; Steigleder GK; Goos M; Meisterernst E
    Z Hautkr; 1982 Apr; 57(8):567-76. PubMed ID: 6124066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochemical distribution of dipeptidylaminopeptidase IV (DAP IV; EC-3.4.14.5) in T-lymphoblastic lymphoma/leukemia characterized with monoclonal antibodies.
    Feller AC; Parwaresch MR; Lennert K
    Leuk Res; 1984; 8(3):397-406. PubMed ID: 6379309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidylaminopeptidase IV activity in T lymphocyte subsets in B cell non-Hodgkin's lymphomas.
    Cozzi M; Gloghini A; Sulfaro S; Volpe R; Carbone A
    Hum Pathol; 1989 Oct; 20(10):987-93. PubMed ID: 2571558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochemistry of dipeptidylaminopeptidase IV and II in normal and neoplastic lymphoid cells.
    Invernizzi R; Bertolino G; Girino M; Perseghin P; Michienzi M; Nano R
    Blut; 1985 May; 50(5):277-85. PubMed ID: 2859898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtyping of chronic lymphocytic leukemia of T-type by dipeptidylaminopeptidase IV (DAP IV), monoclonal antibodies, and Fc-receptors.
    Feller AC; Parwaresch MR; Lennert K
    Cancer; 1983 Nov; 52(9):1609-12. PubMed ID: 6137274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary gastric peripheral T-cell malignant lymphoma with helper/inducer phenotype. First case report with a complete histological ultrastructural and immunochemical study.
    Kanavaros P; Lavergne A; Galian A; Houdart R; Bernard JF
    Cancer; 1988 Apr; 61(8):1602-10. PubMed ID: 2964894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunocytochemical study of T-cell lymphomas using monoclonal and polyclonal antibodies effective in routinely fixed wax embedded tissues.
    Norton AJ; Isaacson PG
    Histopathology; 1986 Dec; 10(12):1243-60. PubMed ID: 3546052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochemistry of dipeptidylaminopeptidase IV in T lymphoblastic leukaemia-lymphoma.
    Invernizzi R; Perugini O; De Fazio P; Bonetti F; Nespoli BL
    Haematologia (Budap); 1989; 22(3):143-9. PubMed ID: 2573567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large cell lymphomas (reticulum cell sarcomas, histiocytic lymphomas). Correlation of morphologic features with functional markers.
    Azar HA; Jaffe ES; Berard CW; Callihan TR; Braylan RR; Cossman J; Triche TJ
    Cancer; 1980 Sep; 46(6):1428-41. PubMed ID: 6998555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of dipeptidylaminopeptidase-IV in some human T and B cell lines.
    Srivastava MD; Bhargava AK
    Acta Haematol; 1986; 76(1):25-8. PubMed ID: 2878556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell lymphomas morphologically resembling T-cell lymphomas.
    Mirchandani I; Palutke M; Tabaczka P; Goldfarb S; Eisenberg L; Pak MS
    Cancer; 1985 Oct; 56(7):1578-83. PubMed ID: 3875393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.
    Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H
    Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Hodgkin's lymphomas: an ultrastructural study correlating morphology with immunologic cell type.
    Said JW; Hargreaves HK; Pinkus GS
    Cancer; 1979 Aug; 44(2):504-28. PubMed ID: 383256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.